Species-specific sensitivity of coagulase-negative staphylococci to single antibiotics and their combinations

Polish Journal of Microbiology

Volumn 60, Issue 2, 2011, Pages 155-161

  Szymanska, Grazyna ^a   Szemraj, Magdalena ^a   Szewczyk, Eligia M ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Antibiotic synergism; Methicillin resistant CNS; Staphylococci infections treatment; Staphylococcus sp

Indexed keywords

CEFALOTIN; CLOXACILLIN; GENTAMICIN; OXACILLIN; RIFAMPICIN; VANCOMYCIN;

BACTERIAL STRAIN; COAGULASE NEGATIVE STAPHYLOCOCCUS; HUMAN; MEDICAL STAFF; NONHUMAN; SHORT SURVEY; SPECIES DIFFERENCE; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS HAEMOLYTICUS; STAPHYLOCOCCUS HOMINIS;

STAPHYLOCOCCUS; STAPHYLOCOCCUS COHNII; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS HAEMOLYTICUS; STAPHYLOCOCCUS HOMINIS;

EID: 80054881688     PISSN: 17331331     EISSN: None     Source Type: Journal    
DOI: 10.33073/pjm-2011-022     Document Type: Short Survey

References (28)

1. Bourgeois I., M. Pestel-Caron, J. Lemeland, J.L. Pons and F. Caron. 2007. Tolerance to the glycopeptides vancomycin and teicoplanin in coagulase-negative staphylococci. Antimicrob. Agents Chemiother. 51: 740-743. (Pubitemid 46185298)
2. Chandran A.U. and R. Rennie. 2005. Routine antimicrobial susceptibility testing of coagulase-negative staphylococci isolated from blood cultures: is it necessary? Clin. Microbiol. Infect. 11: 1037-1040. (Pubitemid 41748941)
3. Climo M.W, R.L. Patron and G.L. Archer. 1999. Combinations of vancomycin and β-lactams are synergistic against staphylococci with reduced susceptibilities to vancomycin. Antimicrob. Agents Chemiother. 43: 1747-1753. (Pubitemid 29331259)
4. Clinical and Laboratory Standards Institute. 2008. Performance standards for antimicrobial Susceptibility testing. Eighteenth Informational Supplement. M100-S18. CLSI, Wayne, PA, USA.
5. Dawis M.A., H.D.Isenberg, K.A. France and S.G. Jenkins. 2003. In vitro activity of gatifloxacin alone and in combination with cefepime, meropenem, piperacillin and gentamicin against multi-drug-resistant organism. J. Antimicrob. Chemother. 51: 1203-1211. (Pubitemid 36622076)
6. Finkelstein R., R. Fusman, I. Oren, I. Kassis and N. Hashman. 2002. Clinical and epidemiologic significance of coagulase-negative staphylococci bacteremia in a tertiary care university Israeli hospital. Am. J. Infect. Control. 30: 21-5 (Pubitemid 34155278)
7. Fox P.M., R.J. Lampen, K.S. Stumpf, G.L. Archer and M.W. Climo. 2006. Succesful therapy of experimental endocarditis caused by vancomycin-resistant Staphylococcus aureus with a combination of vancomycin and β-lactam antibiotics. Antimicrob. Agents Chemiother. 50: 2951-2956. (Pubitemid 44396397)
8. Frigatto E.A., A.M. Machado, A.C. Pignatari and A.C. Gales. 2005. Is the cefoxitin disk test reliable enough to detect oxacillin resistance in coagulase-negative staphylococci? J. Clin. Microbiol. 43: 2028-2029.
9. Guerrero M.L.F. and M. Górgolas. 2006. Comparative activity of cloxacillin and vancomycin against methicillin-susceptible Staphylococcus aureus experimental endocarditis. J. Antimicrob. Chemother. 58: 1066-1069.
10. Hamels S., J.L. Gala, S. Dufour, P. Vannuffel, N. Zammatteo and J. Remacle. 2001. Consensus PCR and microarray for diagnosis of the genus Staphylococcus species, and methicillin resistance. Biotechniq. 31: 1364-6
11. John M.A., C. Pletch and Z. Hussain. 2002. In vitro activity of quinupristin/dalfopristin, linszolid, telithromycin and comparator antimicrobial agents against 13 species of coagulase-negative staphylococci. J. Antimicrob. Chemother. 50: 933-938. (Pubitemid 36032814)
12. Kloos W.E. 1997. Taxonomy and systematic of staphylococci indigenous to humans. pp. 123-125. In: Crossley K.B. and G.L. Archer (eds). The Staphylococci in Human Disease. Churchill Livingstone, London.
13. Kloos W.E. and T.L. Bannerman. 1994. Update on clinical significance of coagulase-negative staphylococci. Clin. Microbiol. Rev. 7: 117-140. (Pubitemid 24038092)
14. Krediet T.G., M.E. Jones, L.J. Gerards and A. Fleer. 1999. Clinical outcome of cephalotin versus vancomycin therapy in the treatment of coagulase-negative staphylococcal septisemia in neonates: Relation to methicillin resistance and mec A gene carriage of blood isolates. Pediatrics 103: 3
15. Kuti J.L., C.R.V. Kiffer, C.M.F. Mendes and D.P. Nicolau. 2008. Pharmacodynamics comparsion of linezolid, teicoplanin and vancomycin against clinical isolates of Staphylococcus aureus and coagulase- negative staphylococci collected from hospitals in Brasil. Clin. Microbiol. Infect. 14: 116-123.
16. Lawrence S.L., V. Roth, R. Slinger, B. Toye, I. Gaboury and B. Lemyre. 2005. Cloxacillin versus vancomycin for presumed lateonset sepsis in the Neonatal Intensive care Unit and the impact upon outcome of coagulase negative staphylococcal bacteremia: a retrospective cohort study. BMC Pediatrics 5: 49.
17. Lee D., H. Chun, D. Yim, S.M. Choi, J.H. Choi, J.H. Yoo, W.S. Shin and M.W. Kang. 2003. Efficacies of vancomycin, arbekacin, and gentamicin alone or in combination against methicillin-resistant Staphylococcus aureus in an in vitro infective endocarditis model. Antimicrob. Agents Chemiother. 47: 3768-3773. (Pubitemid 37484986)
18. Martins A. and R.S. Cunha Maria de Lourdes. 2007. Methicillin resistance in Staphylococcus aureus and coagulase-negative staphylococci: Epidemiological and molecular aspects. Microbiol. Immunol. 51: 787-795. (Pubitemid 47450475)
19. Miranda-Nowales G., B.E. Leanos-Miranda, M. Vilchis-Perez and F. Solórzano-Santos. 2006. In vitro activity effects of combinations of cephalotin, dicloxacillin, imipenem, vancomycin and amikacin against methicillin-resistant Staphylococcus spp. strains. Ann. Clin. Microb. Antimicrob. 5: 25.
20. Nowak T, E. Balcerczak, M. Mirowski and E.M. Szewczyk. 2006. Detection of methicillin resistance in hospital environmental strains of coagulase-negative staphylococci. Pol. J. Microbiol. 55: 339-343. (Pubitemid 46091580)
21. Szewczyk E.M., A. Piotrowski and M. Rózalska. 2000. Predominant staphylococci in the intensive care unit of a pediatric hospital. J. Hosp. Infec. 45: 145-154. (Pubitemid 30438978)
22. Szewczyk E.M., M. Rózalska, T. Cieslikowski and T. Nowak. 2004. Plasmids of Staphylococcus cohnii isolated from the intensive-care unit. Folia Microbiol. 49: 123-131. (Pubitemid 38693140)
23. Tacconelli E., E.M.C. D'Agata and A.W. Karchmer. 2003. Epidemiological comparison of true methicillin-resistant and methicillin-susceptible coagulase-negative staphylococcal bacteremia at hospital admission. Clin. Infect. Dis. 37: 644-649. (Pubitemid 37100803)
24. Tan T.Y., S.Y. Ng, W.X. Ng. 2006. Clinical significance of coagulase- negative Staphylococci recovered from nonsterile sites. J. Clin. Microbiol. 44: 3413-3414. (Pubitemid 44413792)
25. Van Griethuysen A., M. Pouw, van Leewen M. Heck, P. Willemse, A. Buiting, and J. Kluytmans. 1999. Rapid slide latex agglutination test for detection of methicillin resistance in Staphylococcus aureus. J. Clin. Microbiol. 37: 2789-2792. (Pubitemid 29391888)
26. Walsh T.R., A. Bolmström, A. Qwärnström, P. Ho, M. Wootton, R.A. Howe, A.P. MacGowan, and D. Diekema. 2001. Evaluation of current methods for detection of Staphylococci with reduced susceptibility to glycopeptides. J. Clin. Microbiol. 39: 2439-2444. (Pubitemid 32606216)
27. Wang Y.C. and M. Lipstich. 2006. Upgrading antibiotic use within a class: Tradeoff between resistance and treatment success. PNAS. 103: 9655-9660 (Pubitemid 43955880)
28. Weinstein M.P., S. Mirrett, L. van Pelt, M. Mc-Kinnon, B.L. Zimmer, W. Kloos and L.B. Reller. 1998. Clinical importance of identifying coagulase-negative staphylococci isolated from blood cultures: Evaluation of microscan rapid and dried overnight gram-positive panels versus a conventional reference method. J. Clin. Microbiol. 36: 2089-2092 (Pubitemid 28277810)